Literature DB >> 16427224

Calorimetric investigation of protein/amino acid interactions in the solid state.

Fei Tian1, Samir Sane, J Howard Rytting.   

Abstract

Possible protein/amino acid interactions and the physical states of amino acids after freeze-drying have been studied using isoperibol calorimetry and differential scanning calorimetry (DSC). Good linear correlations (R(2) = 0.99) between the enthalpies of solution and the percentage of antibody in all physical mixtures, as well as unchanging melting temperatures of amino acids for physical mixtures demonstrated that there is no interaction between the antibodies and amino acids studied upon physical mixing. On the other hand, positive deviations for antibody/histidine and antibody/arginine freeze-dried samples obtained from the isoperibol calorimetry results demonstrated that molecular level interactions, such as ion-dipole or electrostatic interactions or hydrogen bonding, occur between antibodies and histidine or arginine. The values of DeltaH(interaction) for antibody/histidine (1:1, w/w) and antibody/arginine (1:1, w/w) lyophilized samples were approximately 8 kJ/mol. These interactions were also confirmed by decreased and/or the disappearance of melting temperatures of the amino acids with DSC measurements. A negative deviation from linearity was detected for antibody/aspartic acid lyophilized samples which indicated partial amorphization of aspartic acid. No deviation from linearity as well as similar melting temperatures of antibody/glycine lyophilized samples indicated the absence of interactions between the antibodies and glycine upon freeze-drying.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16427224     DOI: 10.1016/j.ijpharm.2005.12.009

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

Review 1.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

2.  Investigation of a Degradant in a Biologics Formulation Buffer Containing L-Histidine.

Authors:  Chunlei Wang; Aaron Yamniuk; Jun Dai; Sike Chen; Paul Stetsko; Noah Ditto; Yingru Zhang
Journal:  Pharm Res       Date:  2015-02-12       Impact factor: 4.200

3.  Buffer-dependent fragmentation of a humanized full-length monoclonal antibody.

Authors:  Branden A Salinas; Hasige A Sathish; Ambarish U Shah; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2010-07       Impact factor: 3.534

4.  Strategies to stabilize compact folding and minimize aggregation of antibody-based fragments.

Authors:  Diana Gil; Adam G Schrum
Journal:  Adv Biosci Biotechnol       Date:  2013-04

Review 5.  Drying Technologies for the Stability and Bioavailability of Biopharmaceuticals.

Authors:  Fakhrossadat Emami; Alireza Vatanara; Eun Ji Park; Dong Hee Na
Journal:  Pharmaceutics       Date:  2018-08-17       Impact factor: 6.321

6.  Spray-Dried Formulation of Epicertin, a Recombinant Cholera Toxin B Subunit Variant That Induces Mucosal Healing.

Authors:  Micaela A Reeves; Joshua M Royal; David A Morris; Jessica M Jurkiewicz; Nobuyuki Matoba; Krystal T Hamorsky
Journal:  Pharmaceutics       Date:  2021-04-18       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.